Influence of gender and brain region on neurosteroid modulation of GABA responses in rats

Life Sciences

Volumn 60, Issue 19, 1997, Pages 1679-1691

  Wilson, Marlene A ^a   Biscardi, Rosemary ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

aminobutyric acid (GABA); androgen; chloride influx; neurosteroid; regional differences; sex differences; tetrahydrodeoxycorticosterone; tetrahydroproge sterone

Indexed keywords

4 AMINOBUTYRIC ACID; ANDROSTERONE; CHLORINE 36; DIHYDROANDROSTERONE; NEUROSTEROID; TETRAHYDRODEOXYCORTICOSTERONE; TETRAHYDROPROGESTERONE; UNCLASSIFIED DRUG;

ADRENALECTOMY; AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CHLORIDE TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; GENDER; GONADECTOMY; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NEUROMODULATION; NONHUMAN; PREOPTIC AREA; RAT; SEX DIFFERENCE;

AMYGDALA; ANDROGENS; ANDROSTERONE; ANIMALS; BRAIN; CEREBELLUM; CEREBRAL CORTEX; CHLORIDES; DESOXYCORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; MALE; PREGNANOLONE; RATS; SEX CHARACTERISTICS;

EID: 0030908224     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00110-0     Document Type: Article

References (47)

1. M.D. MAJEWSKA, N.L. HARRISON, R.D. SCHWARTZ, J.L. BARKER AND S.M. PAUL, Science 232 1004-1007 (1986).
2. N.L. HARRISON, M.D. MAJEWSKA, J.W. HARRINGTON AND J.L. BARKER, J. Pharm. Exp. Ther. 241 346-353 (1987).
3. B.S. MCEWEN, TIPS 12 141-146 (1991).
4. M.A. WILSON, Crit. Rev. Neurobiol. 10 1-37 (1996).
5. H. CALLACHAN, G.A. COTTRELL, N.Y. HATHER, J.J. LAMBERT, J.M. NOONEY AND J.A. PETERS, Proc. R. Soc. Lond. 237 359-369 (1987).
6. J.J. LAMBERT AND J.A. PETERS, Allosteric Modulation of Amino Acid Receptors: Therapeutic Implications, E.A. Barnard and E. Costa (eds), 139-155, Raven Press, Ltd. New York (1989).
7. S.S. SMITH, Prog. Neurobiol. 44 55-86 (1994).
8. R.H. PURDY, A.L. MORROW, J.R. BLINN AND S.M. PAUL, J. Med. Chem. 33 1572-1581 (1990).
9. A.L. MORROW, P.D. SUZDAK AND S.M. PAUL, Europ. J. Pharmacol. 142 483-485 (1987).
10. G. PUIA, I. DUCIC, S. VICINI AND E. COSTA, Recept. Channels 1 135-142 (1993).
11. R.M. WOODWARD, L. POLENZANI AND R. MILEDI, Molecular Pharmacology 41 89-103 (1992).
12. G. PUIA, M. SANTI, S. VICINI, D.B. PRITCHETT, R.H. PURDY, S.M. PAUL, P.H. SEEBURG AND E. COSTA, Neuron 4 759-765 (1990).
13. R. SHINGAI, M.L. SUTHERLAND AND E.A. BARNARD, Eur. J. Pharm. -Mol. Pharm. Sect. 205 77-80 (1991).
14. H. SELYE, Endocrin. 30 437-453 (1942).
15. D. BITRAN, R.H. PURDY AND C.K. KELLOGG, Pharm. Biochem. Behav. 45 423-428 (1993).
16. J.N. CRAWLEY, J.R. GLOWA, M.D. MAJEWSKA AND S.M. PAUL, Brain Res. 398 382-385 (1986).
17. S. WIELAND, N.C. LAN, S. MIRASEDEGHI AND K.W. GEE, Brain Res. 565 263-268 (1991).
18. D.A. FINN AND K.W. GEE, J. Pharm. Exp. Ther. 271 164-170 (1994).
19. M.A. WILSON, Brain Res. Bull. 29 165-172 (1992).
20. C. KUBLI-GARFIAS, E. CANCHOLA, J. ARAUZ-CONTRERAS AND A. FERIA-VELASCO, Neuroscience 7 2777-2782 (1982).
21. M. VINCENS, E. DARTOIS, M. POPELIER, C. MARQUETTE, E. MOYSE, G. PILLION AND F. HAOUR, Brain Res. Bull. 32 251-256 (1993).
22. D.W. SAPP, U. WITTE, D.M. TURNER, B. LONGONI, N. KOKKA AND R.W. OLSEN, J. Pharm. Exp. Ther. 262 801-808 (1992).
23. A. JUSSOFIE, Acta Endocrin. 729 480-485 (1993).
24. D.A. FINN AND K.W. GEE, J. Pharm. Exp. Ther. 265 1374-1379 (1993).
25. M.A. SIMMONDS, J.P. TURNER AND N.L. HARRISON, Neuropharm. 877-878 (1984).
26. M.S. ERSKINE AND E. KORNBERG, Life Sciences 57 2065-2071 (1992).
27. M.A. WILSON AND R. BISCARDI, Exp. Brain. Res. 707 297-306 (1994).
28. M.A. WILSON AND R. BISCARDI, J. Pharm. Exp. Ther. 266 768-773 (1993).
29. R.A. HARRIS AND A.M. ALLAN, Science 228 1108-1110 (1985).
30. O.H. LOWRY, N.J. ROSEBROUGH, A.L. FARR AND R.J. RANDALL, J. Biol. Chem. 795 265-275 (1951).
31. W. WISDEN, D.J. LAURIE, H. MONYER AND P.H. SEEBURG, J. Neurosci. 72 1040-1062 (1992).
32. S.M. PAUL AND R.H. PURDY, FASEB Journal 6 2311-2322 (1992).
33. E.R. KORPI AND H. LUDDENS, Molecular Pharmacology 44 87-92 (1993).
34. C.A.E. HAUSER, D. CHESNOY-MARCHAIS, P. ROBEL AND E. BAULIEU, Europ. J. Pharmacol. 289 249-257 (1995).
35. K.W. GEE, Molec. Neurobiol. 2 291-317 (1988).
36. A.L. MORROW, J.R. PACE, R.H. PURDY AND S.M. PAUL, Molecular Pharmacology 37 263-270 (1990).
37. S.O.E. LANDGREN, Epilepsy Res. 70 156-165 (1991).
38. R.H. PURDY, P.H. MOORE, P.N. RAO, N. HAGINO, T. YAMAGUCHI, P. SCHMIDT, D.R. RUBINOW, A.L. MORROW AND S.M. PAUL, Steroids 55 290-296 (1990).
39. R.H. PURDY, A.L. MORROW, P.H. MOORE AND S.M. PAUL, Proc. Natl. Acad. Sci. 88 4553-4557 (1991).
40. A. KORNEYEV, A. GUIDOTTI AND E. COSTA, J. Neurochem. 61 2041-2047 (1993).
41. C. LEGOASCOGNE, P. ROBEL, M. GOUEZOU, N. SANANES, E. BAULIEU AND M. WATERMAN, Science 237 1212-1214 (1987).
42. Y. AKWA, J. YOUNG, K. KABBADJ, M.J. SANCHO, D. ZUCMAN, C. VOURC'H, I. JUNG-TESTAS, Z.Y. HU, C. LEGOASCOGNE, D.H. JO, C. CORPECHOT, P. SIMON, E. BAULIEU AND P. ROBEL, J. Steroid. Biochem. Molec. Biol. 40 71-81 (1991).
43. S.H. MELLON AND C.F. DESCHEPPER, Brain Res. 629 283-292 (1993).
44. N.R. KRIEGER AND R.G. SCOTT, J. Neurochem. 42 887-890 (1984).
45. S.J. BERTICS, P.J. BERTICS, J.L. CLARKE AND H.J. KARAVOLAS, J. Ster. Biochem. 26 321-328 (1996).
46. A.G. MUKHIN, V. PAPADOPOULOS, E. COSTA AND K.E. KRUEGER, Proc. Natl. Acad. Sci. 86 9813-9816 (1989).
47. H.J. KARALOVAS, P.J. BERTICS, D. HODGES AND N. RUDIE, Metabolism of Hormonal Steroids in the Neuroendocrine Structures. F.e. Celotti (ed), 149-170, Raven Press, New York (1984).